Title : SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells.

Pub. Date : 2012 Mar 9

PMID : 22330808






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 SIRT1 overexpression decreases cisplatin-induced acetylation of NF-kappaB p65 subunit and cytotoxicity in renal proximal tubule cells. Cisplatin nuclear factor kappa B subunit 1 Homo sapiens
2 While protein expression of SIRT1 was decreased by cisplatin treatment compared with control buffer treatment, acetylation of NF-kappaB p65 subunit was significantly increased after treatment with cisplatin. Cisplatin nuclear factor kappa B subunit 1 Homo sapiens
3 Overexpression of SIRT1 ameliorated the increased acetylation of p65 of NF-kappaB during cisplatin treatment and cisplatin-induced cytotoxicity. Cisplatin nuclear factor kappa B subunit 1 Homo sapiens
4 Further, treatment of cisplatin-treated HK2 cells with resveratrol, a SIRT1 activator, also decreased acetylation of NF-kappaB p65 subunit and cisplatin-induced increase of the cell viability in HK2 cells. Cisplatin nuclear factor kappa B subunit 1 Homo sapiens
5 Our findings suggests that the regulation of acetylation of p65 of NF-kappaB through SIRT1 can be a possible target to attenuate cisplatin-induced renal cell damage. Cisplatin nuclear factor kappa B subunit 1 Homo sapiens